secwatch.observer — SEC 8-K summary
======================================

Issuer:     NutriBand Inc. (NTRB)
CIK:        0001676047
Form:       8-K
Filed at:   2022-01-10T23:59:59+00:00
Accession:  0001213900-22-001256
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nutriband signs feasibility agreement with Kindeva to develop abuse deterrent fentanyl patch AVERSA
--------------------------------------------------------------------------------

- Agreement combines Nutriband's AVERSA abuse deterrent technology with Kindeva's FDA-approved fentanyl patch.
- Partnership focuses on adapting Kindeva's commercial transdermal manufacturing process for AVERSA incorporation.
- Kindeva is a CDMO with 50+ years transdermal experience, formerly 3M Drug Delivery Systems.
- AVERSA technology covered by patents: US notice of allowance, patents in Europe, Japan, Korea, Russia, Mexico, Australia.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1676047/000121390022001256/0001213900-22-001256-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1676047/000121390022001256/ea153757-8k_nutriband.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-001256

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer